Company Information
USD
1.5
- (-1.3%)
NASDAQ:GOVX, GEOVAX LABS, INC.
Industry: Biotechnology
End of Day: 19 April 2024 GMT-4
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Address
1900 Lake Park Drive
Suite 380
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. David A. Dodd
CEO/Chairman of the Board/Director/President
Mr. Mark W. Reynolds, C.P.A.
CFO/Chief Accounting Officer/Secretary
Dr. Randal D. Chase, PhD
Director
Mr. Dean G. Kollintzas
Director
Mr. John N. Spencer, Jr., C.P.A.
Director
Dr. Robert T. McNally,PhD
Director
Ms. Nicole Lemerond
Director
Dr. Jayne Morgan, M.D.
Director
Dr. Mark J. Newman, PhD
Chief Scientific Officer
Dr. Kelly T. McKee, M.D.
Chief Medical Officer
Dr. John W. Sharkey, PhD
Vice President, Divisional
Ownership
Institution Holdings
Vanguard Group Inc
728,443 (2.236%)
BlackRock Inc
413,444 (1.269%)
Geode Capital Management, LLC
172,895 (0.531%)
State Street Corporation
97,942 (0.301%)
Barclays Global Investors NA
93,854 (0.288%)
BlackRock
81,880 (0.251%)
Morgan Stanley - Brokerage Accounts
50,197 (0.154%)
Northern Trust Investments Inc
45,415 (0.139%)
Northern Trust Corp
34,214 (0.105%)
Vanguard Investments Australia Ltd
29,853 (0.092%)
Funds Holdings
BlackRock Extended Equity Market
81,880 (0.251%)
Vanguard US Total Market Shares ETF
29,853 (0.092%)
Vanguard Total Stock Market Index Fund
29,325 (0.090%)
Vanguard Institutional Extnd Mkt Idx Tr
19,238 (0.059%)
NT Ext Equity Mkt Idx Fd - DC - NL
11,201 (0.034%)
Extended Equity Market Fund M
10,124 (0.031%)
SSgA U.S. Total Market Index Fund
2,913 (0.009%)
Fidelity Series Total Market Index Fund
2,071 (0.006%)
NT Ext Equity Mkt Indx Fd DC Lending
451 (0.001%)
Spartan Total Market Index Pool
134 (0.000%)
Make Smart Investment Choices